Total Payments
$7,628
2024 Payments
$922.78
Companies
27
Transactions
323
Medicare Patients
3,673
Medicare Billing
$358,418
Payment Breakdown by Category
Food & Beverage$7,603 (99.7%)
Education$24.36 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,603 | 320 | 99.7% |
| Education | $24.36 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,489 | 87 | $0 (2024) |
| Novo Nordisk Inc | $758.96 | 45 | $0 (2024) |
| ABBVIE INC. | $717.90 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $679.68 | 39 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $598.54 | 5 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $532.11 | 17 | $0 (2021) |
| Amgen Inc. | $503.82 | 10 | $0 (2024) |
| Lilly USA, LLC | $500.17 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $314.22 | 5 | $0 (2022) |
| Amarin Pharma Inc. | $285.90 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $922.78 | 31 | AstraZeneca Pharmaceuticals LP ($289.86) |
| 2023 | $659.94 | 29 | ABBVIE INC. ($208.52) |
| 2022 | $908.80 | 47 | ABBVIE INC. ($278.16) |
| 2021 | $1,238 | 48 | Biohaven Pharmaceuticals, Inc. ($598.54) |
| 2020 | $474.24 | 29 | AstraZeneca Pharmaceuticals LP ($116.85) |
| 2019 | $1,389 | 56 | Novo Nordisk Inc ($308.77) |
| 2018 | $757.71 | 38 | Novo Nordisk Inc ($156.56) |
| 2017 | $1,276 | 45 | Janssen Pharmaceuticals, Inc ($228.43) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $117.70 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $110.62 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: RESPIRATORY | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Gastroenterology | ||||||
| 03/20/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 645 | 1,207 | $125,435 | $65,316 |
| 2022 | 15 | 707 | 1,466 | $144,200 | $79,764 |
| 2021 | 19 | 963 | 2,018 | $190,465 | $99,249 |
| 2020 | 22 | 1,358 | 2,998 | $264,282 | $114,089 |
Total Patients
3,673
Total Services
7,689
Medicare Billing
$358,418
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 228 | $34,200 | $19,047 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 190 | $20,900 | $12,772 | 61.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 54 | 54 | $8,100 | $6,644 | 82.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 34 | 82 | $7,790 | $5,427 | 69.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 29 | 66 | $7,920 | $5,257 | 66.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 53 | 53 | $6,625 | $3,963 | 59.8% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 13 | 15 | $7,500 | $3,086 | 41.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 19 | 88 | $4,400 | $2,191 | 49.8% |
| 92548 | Test for balance and posture | Office | 2023 | 45 | 46 | $4,600 | $1,613 | 35.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 50 | 50 | $5,000 | $1,261 | 25.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 71 | $3,550 | $1,014 | 28.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 56 | 56 | $2,800 | $955.92 | 34.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 53 | 53 | $2,650 | $904.71 | 34.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 44 | $1,100 | $443.97 | 40.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 50 | 55 | $5,500 | $378.95 | 6.9% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 51 | 56 | $2,800 | $359.42 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 264 | $39,600 | $23,355 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 232 | $25,520 | $15,010 | 58.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 59 | 201 | $19,095 | $12,568 | 65.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $8,400 | $6,994 | 83.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 28 | 61 | $7,310 | $5,822 | 79.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 59 | 59 | $7,375 | $4,731 | 64.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 28 | 141 | $7,050 | $3,630 | 51.5% |
| 92548 | Test for balance and posture | Office | 2022 | 46 | 46 | $4,600 | $1,691 | 36.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 57 | 57 | $5,700 | $1,462 | 25.7% |
About Dr. Ajay Patel, M.D
Dr. Ajay Patel, M.D is a Internal Medicine healthcare provider based in Saint Albans, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023078912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajay Patel, M.D has received a total of $7,628 in payments from pharmaceutical and medical device companies, with $922.78 received in 2024. These payments were reported across 323 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,603).
As a Medicare-enrolled provider, Patel has provided services to 3,673 Medicare beneficiaries, totaling 7,689 services with total Medicare billing of $358,418. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Saint Albans, WV
- Active Since 03/24/2006
- Last Updated 09/22/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023078912
Products in Payments
- FARXIGA (Drug) $876.04
- NURTEC ODT (Drug) $598.54
- UBRELVY (Drug) $552.95
- XARELTO (Drug) $532.11
- TRELEGY ELLIPTA (Drug) $518.02
- Ozempic (Drug) $446.28
- Repatha (Biological) $320.21
- JARDIANCE (Drug) $300.93
- Vascepa (Drug) $285.90
- TRULICITY (Drug) $238.67
- AJOVY (Drug) $179.02
- AIRSUPRA (Drug) $178.17
- ELIQUIS (Drug) $156.41
- SYMBICORT (Drug) $143.20
- Tresiba (Drug) $135.04
- QULIPTA (Drug) $134.95
- Inpefa (Drug) $125.00
- Aimovig (Biological) $124.98
- RYBELSUS (Drug) $107.28
- TOUJEO (Drug) $103.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Saint Albans
Dr. William Johnson
Internal Medicine — Payments: $3,322
Internal Medicine $3,322
Dr. Eiad Youssef, M.d, M.D
Internal Medicine — Payments: $300.74
Internal Medicine $300.74
Keisha Bryant, Md, MD
Internal Medicine — Payments: $233.94
Internal Medicine $233.94
Ernest Tonski, Md, MD
Internal Medicine
Internal Medicine
Dr. Linda Collins, M.d, M.D
Internal Medicine
Internal Medicine
Jay Stearns, Md, MD
Internal Medicine
Internal Medicine